Found: 16
Select item for more details and to access through your institution.
Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09664-1
- By:
- Publication type:
- Article
Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3129, doi. 10.3390/ijms24043129
- By:
- Publication type:
- Article
Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.50960
- By:
- Publication type:
- Article
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.13426
- By:
- Publication type:
- Article
Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.822298
- By:
- Publication type:
- Article
Role of HLA-G in Viral Infections.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.826074
- By:
- Publication type:
- Article
NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02040
- By:
- Publication type:
- Article
Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 648, doi. 10.1038/mt.2015.2
- By:
- Publication type:
- Article
CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1290488
- By:
- Publication type:
- Article
Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1270243
- By:
- Publication type:
- Article
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.714799
- By:
- Publication type:
- Article
Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.705848
- By:
- Publication type:
- Article
Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 7, p. 781, doi. 10.3390/v12070781
- By:
- Publication type:
- Article
Disarming Cellular Alarm Systems--Manipulation of Stress-induced NKG2D Ligands by Human Herpesviruses.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00390
- By:
- Publication type:
- Article
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1641, doi. 10.3390/biomedicines12081641
- By:
- Publication type:
- Article
The Impact of Obesity on T and NK Cells after LVAD Implantation.
- Published in:
- Obesity Facts: The European Journal of Obesity, 2023, v. 16, n. 4, p. 364, doi. 10.1159/000530174
- By:
- Publication type:
- Article